Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.04 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 90.63% year-over-year to 0.04, compared with a TTM value of 0.04 through Dec 2025, up 90.63%, and an annual FY2025 reading of 0.04, up 30.02% over the prior year.
  • Asset Utilization Ratio was 0.04 for Q4 2025 at Agios Pharmaceuticals, up from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.04 in Q4 2025 and bottomed at 0.09 in Q3 2021.
  • Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.02 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio crashed 145.12% in 2021, then skyrocketed 2552.53% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.09 in 2021, then skyrocketed by 112.64% to 0.01 in 2022, then surged by 134.35% to 0.03 in 2023, then decreased by 23.42% to 0.02 in 2024, then skyrocketed by 90.63% to 0.04 in 2025.
  • Business Quant data shows Asset Utilization Ratio for AGIO at 0.04 in Q4 2025, 0.03 in Q3 2025, and 0.03 in Q2 2025.